What is Neurobiological Technologies, Inc. (NTII) stock price today?

Neurobiological Technologies, Inc. (NTII) is currently trading at $0.00.

What is NTII P/E ratio?

Neurobiological Technologies, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is NTII return on equity (ROE)?

Neurobiological Technologies, Inc.'s return on equity (ROE) is 24.90%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Neurobiological Technologies, Inc.'s market cap?

Neurobiological Technologies, Inc. has a market capitalization of $2702.

OTC · Biotechnology

Neurobiological Technologies, Inc. (NTII) Stock

$0.00 OTC: NTII Healthcare

Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009.

Valuation

Metric	Value
Price	$0.00
Market Cap	$2702
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$0.12
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	24.90%
ROA	121.05%
ROCE	139.25%
Gross Margin	99.50%
Operating Margin	13.25%
Net Margin	11.85%
Debt/Equity	0.00
Current Ratio	35.34

Annual Financials (USD)

Metric	2005	2006	2007	2008	2009
Revenue	$12.0M	$18.0M	$15.0M	$26.0M	—
Operating Profit	$-28.0M	$-16.0M	$-17.0M	$3.0M	—
Net Profit	$-28.0M	$-14.0M	$-16.0M	$3.0M	—
EPS	$-6.86	$-3.26	$-0.84	$0.12	—
Op Margin	-226.4%	-88.3%	-113.1%	13.3%	—

Balance Sheet (USD)

Metric	2005	2006	2007	2008	2009
Total Assets	$22.0M	$11.0M	$43.0M	$25.0M	$3.0M
Total Liabilities	$34.0M	$33.0M	$23.0M	$1.0M	$1.0M
Cash	$10.0M	$6.0M	$28.0M	$8.0M	$2.0M
Borrowings	$0	$0	$0	$0	$0

Cash Flow (USD)

Metric	2005	2006	2007	2008	2009
Operating Cash Flow	$9.0M	$-13.0M	$-21.0M	$-16.0M	—
Investing Cash Flow	$-1.0M	$2.0M	$-12.0M	$-3.0M	—
Financing Cash Flow	$0	$0	$0	$0	—
Net Cash Flow	$9.0M	$-4.0M	$22.0M	$-20.0M	—
Free Cash Flow	$9.0M	$-13.0M	$-21.0M	$-16.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.57
FCF Yield	-608105.11%
Quick Ratio	35.34
Interest Coverage	0.00
Return 1Y	0.00%
Return 3Y	0.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Ancora Advisors, LLC	85	2026-03-31

Peer Comparison

Ticker	Price	Change	Market Cap	Div Yield
ANTHAnthera Pharmaceuticals, Inc.	$0.00	—	$2618	0.00%
CMRAComera Life Sciences Holdings, Inc.	$0.00	—	$3074	0.00%
COTQFCotinga Pharmaceuticals Inc.	$0.00	—	$2199	0.00%
FORUForU Holdings, Inc.	$0.00	—	$2171	0.00%
GBIMGlobeImmune, Inc.	$0.00	—	—	0.00%

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in 1987, has its primary location in Emeryville, California.

Neurobiological Technologies, Inc. (NTII) stock trades at $0.00 with a market capitalization of $2702. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Neurobiological Technologies, Inc. generates a return on equity (ROE) of 24.90% — well above the market average, a sign of a high-quality business, return on capital employed of 139.25%, an operating margin of 13.25%, a net profit margin of 11.85%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides